JMJun Mu

Jun Mu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Jun Mu has a total of 50 co-authors. Here are the top co-authors by number of shared publications:

  • Huan Zhao

    Department of Neurology, The First Affiliated Hospital of Chongqing Medical University

    7 shared publications
  • Fang Liu

    Department of Neurology, The First Affiliated Hospital of Chongqing Medical University

    6 shared publications
  • Lei Gong

    Department of Neurology, The First Affiliated Hospital of Chongqing Medical University

    6 shared publications
  • Zhiwen Yan

    Department of Neurology, The First Affiliated Hospital of Chongqing Medical University

    5 shared publications
  • Jie Zhang

    Department of Neurology, The First Affiliated Hospital of Chongqing Medical University

    4 shared publications
  • Wenxia Jiang

    Department of Neurology, The First Affiliated Hospital of Chongqing Medical University, No.1 Yixueyuan Road, Chongqing, China

    4 shared publications

Latest Publications

  • Open Access

    Identifying key predictors of post-stroke depression and cognitive impairment in acute stroke survivors

    by Zhiwen Yan, Huan Zhao, Jianjun Chen, Fang Liu, Lei Gong, Yingli Li, Jie Zhang, Mi Xiao, Jun Mu

    Background: Post-stroke depression (PSD) and post-stroke cognitive impairment (PSCI) are prevalent complications in aging stroke survivors and are often overlooked due to the lack of early diagnostic indicators, leading to poor prognosis. Identifying reliable predictors is crucial for timely intervention. Methods: This prospective cohort study followed 78 acute stroke survivors for 6 months. A composite neuropsychological outcome—defined as the development of PSD and/or PSCI—was determined using the Diagnostic and Statistical Manual of Mental Disorders-5th Edition (DSM-5) and NINDS-CSN criteria. To account for the limited sample size, multivariable Firth’s penalized logistic regression was employed to identify independent predictors, generating robust odds ratios (ORs) and 95% confidence intervals (CIs). An exploratory classification and regression tree (CART) analysis was also conducted for hypothesis generation. Results: The final cohort comprised 78 acute ischemic stroke survivors with a median age of 62 years (IQR 51–71). Among these participants, 26.0% were women, and the median admission score on the National Institutes of Health Stroke Scale (NIHSS) was 3 (IQR 1–5). Within 6 months, 56 patients (71.8%) developed the composite outcome (13 experienced PSCI alone, 24 had PSD alone, and 19 had both conditions). A multivariable analysis revealed that right hemisphere lesions (OR = 9.019, 95% CI: 1.329–61.213, p = 0.016), greater baseline emotional distress (higher 9-item Patient Health Questionnaire (PHQ-9) scores; OR = 5.157, 95% CI: 1.835–14.494, p < 0.001), and pre-existing cognitive vulnerability (lower Mini–Mental State Examination (MMSE) scores; OR = 0.714, 95% CI: 0.517–0.984, p = 0.023) were independent predictors of poor neuropsychological outcomes. Advanced age ( p = 0.094) and elevated urea levels ( p = 0.095) showed only marginal trends. Exploratory CART modeling highlighted the hierarchical interaction of these baseline clinical scores for risk stratification. Conclusion: Right hemisphere lesions, early emotional distress, and baseline cognitive vulnerability independently predicted a high risk of composite neuropsychological impairment at 6 months post-stroke. Rather than serving merely as novel biomarkers, high baseline PHQ-9 scores and low MMSE scores reflected the persistence of early distress and poor cognitive reserve, respectively. These highly accessible clinical parameters facilitate early risk stratification, emphasizing the absolute need for immediate psychological triage and integrated, long-term cognitive-emotional monitoring.


  • Open Access

    Investigating the association between the food inflammation scores of individuals and stroke in adults: an extreme gradient boosting machine learning model interpreted with shapley additive explanations

    by Zhiwen Yan, Kang Luo, Qinghuan Yang, Xiaoqing Liu, Huan Zhao, Yuan Gao, Qiang Zhang, Jun Mu

    Background: Chronic systemic inflammation is a pivotal modifiable risk factor for stroke. The food-based Food Inflammation Index (FII) offers a novel approach to assess dietary inflammatory potential, yet the association between its derivative, the Food Inflammation Scores of Individuals (FISI), and stroke prevalence remains to be elucidated. Methods: This study analyzed a cohort of 19,681 adults from the NHANES (2007–2018) database. The FISI-stroke association was assessed using multivariable logistic regression and machine learning models (XGBoost), interpreted via SHAP analysis. Results: Higher FISI scores were positively associated with increased stroke prevalence in a dose-dependent manner. Specifically, a one-unit rise in FISI34, FISI26-USDA, and FISI26-CHINA corresponded to 7%, 18%, and 22% higher stroke odds, respectively. XGBoost modeling identified FISI34 as a key predictor, corroborating regression findings. Conclusions: This study establishes a robust link between higher FISI, derived from the FII, and stroke risk. The FII framework surpasses nutrient-based indices by providing personalized, actionable, food-specific guidance for stroke prevention through anti-inflammatory diets. Graphical


  • Open Access

    From nutrient-based to food-based assessment: the evolution of inflammatory indices and their significance for metabolic syndrome and type 3 diabetes mellitus

    by Li Tao, Yangtao Liu, Jiayi Li, Jie Zhang, Huan Zhao, Kang Luo, Yuan Gao, Jun Mu, Qinghuan Yang, Zhiwen Yan

    Chronic low-grade inflammation has emerged as the pivotal driver connecting metabolic syndrome (MetS) and type 2 diabetes mellitus (T2DM) to neurodegenerative disorders, a pathological continuum increasingly recognized as “Type 3 Diabetes Mellitus” (T3DM). Diet, as a primary modifiable lifestyle factor, plays a dual role as both an inflammatory trigger and a potential therapeutic target. This review systematically delineates the methodological evolution of dietary inflammatory indices, shifting from the reductionist, nutrient-centric logic of the Dietary Inflammatory Index (DII) to the systemic, “food-matrix-based” logic of the recently proposed Food Inflammation Index (FII). We provide an in-depth mechanistic synthesis of the gut-metabolism-brain axis, illustrating how high-inflammatory diets initiate a malignant cascade: beginning with gut dysbiosis and barrier leakage, followed by immunometabolic reprogramming of adipose tissue, and culminating in the “Trojan Horse” effect at the blood–brain barrier. This process facilitates amyloid-beta accumulation and bioenergetic crises, forming the molecular basis of T3DM. While the DII remains an irreplaceable tool for large-scale historical and cross-cultural epidemiological research, we argue that the FII represents an important methodological advancement toward precision nutrition. By quantifying intra-group heterogeneity and capturing whole-food effects, the FII is designed to address the clinical “translation bottleneck” of nutrient-based assessments. Furthermore, we explore the clinical integration of the Food Inflammation Scores of Individuals (FISI) with digital health platforms and artificial intelligence, proposing novel, pre-emptive tools such as Children’s FISI (C-FISI) and Pregnancy FISI (P-FISI) for life-cycle management. This review bridges the gap between nutrition science and neuro-metabolic pathology, providing a novel theoretical framework and practical tools for the integrated management of MetS and the early prevention of T3DM.

  • Open Access

    DWI and Clinical Characteristics Correlations in Acute Ischemic Stroke After Thrombolysis

    by Jiayi Li, Cheng Huang, Yangtao Liu, Yingli Li, Jie Zhang, Mi Xiao, Zhiwen Yan, Huan Zhao, XiaoPeng Zeng, Jun Mu

    Objective Magnetic Resonance Diffusion-Weighted Imaging (DWI) is a crucial tool for diagnosing acute ischemic stroke, yet some patients present as DWI-negative. This study aims to analyze the imaging differences and associated clinical characteristics in acute ischemic stroke patients receiving intravenous thrombolysis, in order to enhance understanding of DWI-negative strokes. Methods Retrospective collection of clinical data from acute ischemic stroke patients receiving intravenous thrombolysis at the Stroke Center of the First Affiliated Hospital of Chongqing Medical University from January 2017 to June 2023, categorized into DWI-positive and negative groups. Descriptive statistics, univariate analysis, binary logistic regression, and machine learning model were utilized to assess the predictive value of clinical features. Additionally, telephone follow-up was conducted for DWI-negative patients to record medication compliance, stroke recurrence, and mortality, with Fine-Gray competing risk model used to analyze recurrent risk factors. Results The incidence rate of DWI-negative ischemic stroke is 22.74%. Factors positively associated with DWI-positive cases include onset to needle time (ONT), onset to first MRI time (OMT), NIHSS score at 1 week of hospitalization (NIHSS-1w), hyperlipidemia (HLP), and atrial fibrillation (AF) (p1). Conversely, recurrent ischemic stroke (RIS) and platelet count (PLT) are negatively correlated with DWI-positive cases (pConclusions NIHSS-1w, OMT, ONT, HLP, and AF can predict DWI-positive findings, while platelet count and RIS are associated with DWI-negative cases. AF and HLP demonstrate the highest predictive value. DWI-negative patients have a higher risk of stroke recurrence than mortality in the short term, with a potential correlation between TOAST classification and recurrence risk.


  • Open Access

    Validity of evaluation scales for post-stroke depression: a systematic review and meta-analysis

    by Fang Liu, Lei Gong, Huan Zhao, Ying-Li Li, Zhiwen Yan, Jun Mu

    Background: Post-stroke depression (PSD) is closely associated with poor stroke prognosis. However, there are some challenges in identifying and assessing PSD. This study aimed to identify scales for PSD diagnosis, assessment, and follow-up that are straightforward, accurate, efficient, and reproducible. Methods: A systematic literature search was conducted in 7 electronic databases from January 1985 to December 2023. Results: Thirty-two studies were included, the Patient Health Questionnaire-9 (PHQ-9) and Hamilton Depression Scale (HDRS) had higher diagnostic accuracy for PSD. The sensitivity, specificity, and diagnostic odds ratio of PHQ-9 or diagnosing any depression were 0.82, 0.87, and 29 respectively. And for HDRS, used for diagnosing major depression, the scores were 0.92, 0.89, and 94. Furthermore, these two scales also had higher diagnostic accuracy in assessing depressive symptoms during both the acute and chronic phases of stroke. In patients with post-stroke aphasia and cognitive impairment, highly diagnostic scales have not been identified for assessing depressive symptoms yet. Conclusions: The PHQ-9 and HDRS scales are recommended to assess PSD. HDRS, which demonstrates high diagnostic performance, can replace structured interviews based on diagnostic criteria.


  • Analysis of radiological features in patients with post-stroke depression and cognitive impairment

    by Jun Mu, Jiayi Li

    Post-stroke depression (PSD) and post-stroke cognitive impairment (PSCI) are common complications following a stroke, significantly impacting the quality of life and survival time of survivors. Currently, the comorbidity of PSCI and PSD is receiving increasing attention, as they share some common clinical characteristics, mechanisms, risk factors, radiological features, and treatment strategies. They influence each other, with the clinical prevalence of PSD comorbid with PSCI reaching as high as 26.15 %. The prevention, screening, diagnosis, and treatment of PSD and PSCI require collaboration across clinical, radiological, and neuropsychological evaluations. This paper aims to summarize the common radiological features of both conditions from a radiological perspective, which may aid in identifying early screening and predictive imaging biomarkers.


  • Microbiota-derived short-chain fatty acids may participate in post-stroke depression by regulating host's lipid metabolism

    by Wenxia Jiang, Jianjun Chen, Lei Gong, Fang Liu, Huan Zhao, Zhiwen Yan, Yingli Li, Jie Zhang, Mi Xiao, Jun Mu


  • Alteration of Glycerophospholipid Metabolism in Hippocampus of Post-stroke Depression Rats

    by Wenxia Jiang, Jianjun Chen, Lei Gong, Fang Liu, Huan Zhao, Jun Mu

    Post-stroke depression (PSD) is the most common mental disorder in stroke survivors. However, its specific pathophysiology remains largely unknown. Previous studies suggested a role of hippocampus in PSD. Therefore, we conducted this study to investigate the lipid metabolic signatures in hippocampus of PSD rats. Here, the liquid chromatography mass spectrometry was used to identify the lipid metabolic signatures in the hippocampus of PSD, control and stroke rats. Then, correlations between behavior indices and differential lipid metabolites in PSD rats were explored. Pathway and enrichment analysis were further conducted to uncover the crucial metabolic pathways related to PSD. Finally, we found that the lipid metabolic phenotype in hippocampus of PSD rats was substantially different from that in control and stroke rats, and identified 50 key lipid metabolites that were significantly decreased in PSD rats. These differential metabolites were mainly involved in glycerophospholipid metabolism. Meanwhile, the sucrose preference and immobility time were found to be significantly positively and negatively, respectively, correlated with glycerophospholipid metabolites. The pathway and enrichment analysis showed that the glycerophospholipid metabolism, especially cardiolipin metabolism, was significantly disturbed in PSD rats. These results suggested that the down-regulated glycerophospholipids in hippocampus, especially cardiolipin, might participate in the pathophysiology of PSD. Our findings would be helpful for future exploring the pathophysiology of PSD.


  • Potential markers for predicting delayed encephalopathy in patients with acute carbon monoxide poisoning

    by Chundi Mu, Jianjun Chen, Tengyun Guo, Wenxia Jiang, Lei Gong, Fang Liu, Jun Mu


  • Open Access

    Alteration of Gut Microbiome and Correlated Lipid Metabolism in Post-Stroke Depression

    by Wenxia Jiang, Lei Gong, Fang Liu, Yikun Ren, Jun Mu

    Background: The pathogenesis of post-stroke depression (PSD) remains largely unknown. There is growing evidence indicating that gut microbiota participates in the development of brain diseases through the gut-brain axis. Here, we aim to determine whether and how microbial composition and function altered among control, stroke and PSD rats.Materials and Methods: After the PSD rat model was successfully established, gut microbiome combined with fecal metabolome approach were performed to identify potentially PSD-related gut microbes and their functional metabolites. Then, correlations between behavior indices and altered gut microbes, as well as correlations between altered gut microbial operational taxonomic units (OTUs) with differential metabolites in PSD rats were explored. Enrichment analysis was also conducted to uncover the crucial metabolic pathways related to PSD.Results: Although there were some alterations in the microbiome and metabolism of the control and stroke rats, we found that the microbial and metabolic phenotypes of PSD rats were significantly different. The microbial composition of PSD showed a decreased species richness indices, characterized by 22 depleted OTUs mainly belonging to phylum Firmicutes, genus Blautia and Streptococcus. In addition, PSD was associated with disturbances of fecal metabolomics, among them Glutamate, Maleic acid, 5-Methyluridine, Gallocatechin, 1,5-Anhydroglucitol, L-Kynurenine, Daidzein, Cyanoalanine, Acetyl Alanine and 5-Methoxytryptamine were significantly related to disturbed gut microbiome (P ≤ 0.01). Disordered fecal metabolomics in PSD rats mainly assigned to lipid, amino acid, carbohydrate and nucleotide metabolism. The steroid biosynthesis was particularly enriched in PSD.Conclusions: Our findings suggest that gut microbiome may participate in the development of PSD, the mechanism may be related to the regulation of lipid metabolism.